treatment, guidelines, melanoma, interferon, cutaneous
Treatment Guidelines for Melanoma: Alberta Cancer Board
Adjuvant Interferon in Cutaneous Melanoma
 Open this treatment guideline (PDF)
Developed: May 2007 Revised: June 2009
Goal/Objective
Improving overall survival, disease-free survival, and quality of life for adult patients with high-risk malignant melanoma who are rendered disease-free following resection.
Question Answered
Should adjuvant interferon alpha be offered to patients who have been rendered disease-free following the resection of cutaneous melanomas and who are at high risk for subsequent recurrence?
|
|
|
|
|
|